The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-1438-2020·Announced 2020-08-05

MasterPharm Recalls Tadalafil 26 mg Capsules Due to Processing Controls

MasterPharm LLC is recalling Tadalafil 26 mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or deaths, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

MasterPharm LLC is voluntarily recalling Tadalafil 26 mg capsules, 90 capsules per bottle, distributed nationwide in the U.S. The recall was initiated because of a lack of processing controls, which means there is a lack of assurance that the product conforms to specifications.

The affected product is identified by the following lot codes: 01-27-2020:91@23 with a best use date of 7/25/2020, and 02-26-2020:57@16 with a best use date of 8/24/2020. The total quantity involved is 900 capsules.

Consumers who have purchased this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for further instructions or a refund.

The recalled product

Product
Tadalafil 26 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Manufacturer
MasterPharm LLC
Category
Drug — Prescription Medication
Hazard
Affected units
900

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • 01-27-2020:91@23
  • BUD 7/25/2020 02-26-2020:57@16
  • BUD 8/24/2020

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 26 products in this recall →

Related recalls

Same manufacturer · MasterPharm LLC

See all →

Same hazard · quality control

See all →

Similar recalls